Pre-Application Webinar Information for Cutting Edge Informatics Tools Funding Opportunity Announcement

The NIH held a Technical Assistance webinar for investigators who are planning to submit an application in response to RFA-RM-21-020 and NOT-RM-21-019 on May 26, 2021. The funding opportunity, RFA-RM-21-020, focuses on the development of new cutting edge informatics tools (CEITs) to support the IDG program in the following ways:

1. Develop and deploy tools to enhance the community's ability to process, analyze, and visualize IDG data
2. Prioritize new data resources and methods to be incorporated into Pharos that will strengthen predictions about physiological and disease associations around understudied proteins
3. Develop methods to prioritize understudied IDG proteins for deeper study using experimental assays both within the IDG pipeline or by the larger community.

      Letters of intent are due by June 15, 2021 and applications are due by July 15, 2021.

The webinar provided prospective applicants with information on the IDG Program and addressed questions pertinent to preparing applications. Webinar attendance is optional and is not required for application submission. For more information on the Illuminating the Druggable Genome Program, please visit the program website https://commonfund.nih.gov/idg/. Frequently Asked Questions regarding the RFA will be updated on the Common Fund's IDG website after the webinar. Applicants are encouraged to review the FAQs and the webinar recording prior to submitting their applications.

Webinar Information

• View the webinar slides.
• View the webinar recording.
• View FAQs and their answers. These FAQs were updated on May 19, 2021.
• Please feel free to submit questions to DruggableGenome@mail.nih.gov (link sends e-mail)

Contact Information:

Jerry Li, M.D., Ph.D.

National Cancer Institute (NCI)

Email: DruggableGenome@mail.nih.gov 

Meetings with IDG Representatives

• 14th Annual New Mexico Bioinformatics, Science, and Technology (NMBIST) Symposium on Integrative Omics
  IDG Awardee Dr. Jeremy Yang from the University of New Mexico
  Illuminating the Druggable Genome: Exploring the Unknown
  March 14-15, 2019
  Sante Fe, NM
   

IDG Consortium Meetings

• IDG Implementation Phase Face to Face Meeting
  February 26-27, 2019
  Arlington, VA
   
• IDG Implementation Phase Kick Off Meeting
  March 13-14, 2018
  NIH Campus, Bethesda, MD
   
• IDG Technical Assistance Webinar
  December 13, 2016
  Webinar Recording
   
• IDG Consortium Face-to-Face Meeting
  March 22, 2016
  Residence Inn by Marriott Downtown Bethesda, Bethesda, Maryland, USA
  • Topics presented will include:
    • Integrated Databases: Tudor Oprea (University of New Mexico Health Sciences Center) and Avi Ma'ayan (Icahn School of Medicine at Mount Sinai)
    • Illuminating the Subterranean GPCR-ome: Gary Johnson (University of North Carolina Chapel Hill) 
    • Integration of the Understudied Kinome in Kinase Signaling Networks: Bryan Roth (University of North Carolina Chapel Hill) and Brian Shoichet (University of California, San Francisco)
    • Scalable Zebrafish Tools for Annotating and Manipulating the Druggable Genome in vivo: David Kokel and Jing-Ruey Joanna Yeh (Massachusetts General Hospital)
    • Unlocking the Hidden Genome: Michael McManus (University of California, San Francisco)
    • Identify Ion Channel Modulators Using Novel High-throughput Platform: Susumu Tomita (Yale University)
    • A Physical Exam for Neurons to Identify Functions of Orphan Genes: Gaia Skibinski and Steve Finkbeiner (J. David Gladstone Institutes)
    • Signaling Network of Transcription Factor Crosstalk in Lung Cancer: Yi Wang and Jun Qui (Baylor College of Medicine)